EBSAM
MDT icon

Eubel Brady & Suttman Asset Management’s Medtronic MDT Stock Holding History

Eubel Brady & Suttman Asset Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.3M Buy
335,820
+5,126
+2% +$414K 3.12% 10
2026
Q1 		$28.7M Buy
330,694
+2,469
+0.8% +$237K 3.39% 5
2025
Q4 		$31.5M Sell
328,225
-7,567
-2% -$735K 3.54% 6
2025
Q3 		$32M Buy
335,792
+3,808
+1% +$350K 3.67% 5
2025
Q2 		$28.9M Buy
331,984
+6,639
+2% +$563K 3.66% 6
2025
Q1 		$29.2M Buy
325,345
+1,386
+0.4% +$124K 3.85% 3
2024
Q4 		$25.9M Buy
323,959
+646
+0.2% +$55.9K 3.41% 6
2024
Q3 		$29.1M Buy
323,313
+800
+0.2% +$67.3K 3.8% 5
2024
Q2 		$25.4M Sell
322,513
-12,072
-4% -$990K 3.67% 5
2024
Q1 		$29.2M Sell
334,585
-2,214
-0.7% -$189K 3.71% 6
2023
Q4 		$27.7M Buy
336,799
+36,851
+12% +$2.81M 3.68% 4
2023
Q3 		$23.5M Buy
299,948
+4,577
+2% +$383K 3.43% 6
2023
Q2 		$26M Buy
295,371
+2,539
+0.9% +$219K 3.59% 4
2023
Q1 		$23.6M Buy
292,832
+286,525
+4,543% +$23.4M 3.42% 8
2022
Q4 		$490K Sell
6,307
-260
-4% -$21.1K 0.08% 70
2022
Q3 		$530K Buy
6,567
+3,509
+115% +$315K 0.09% 66
2022
Q2 		$274K Sell
3,058
-59
-2% -$5.98K 0.05% 65
2022
Q1 		$346K Buy
3,117
+585
+23% +$61.8K 0.06% 62
2021
Q4 		$262K Sell
2,532
-43
-2% -$4.98K 0.05% 71
2021
Q3 		$323K Buy
2,575
+165
+7% +$21.4K 0.07% 58
2021
Q2 		$285K Sell
2,410
-2,410
-50% -$303K 0.02% 166
2021
Q1 		$570K Buy
4,820
+2,423
+101% +$284K 0.06% 71
2020
Q4 		$281K Buy
2,397
+20
+0.8% +$2.2K 0.07% 67
2020
Q3 		$247K Buy
2,377
+31
+1% +$3.11K 0.07% 65
2020
Q2 		$215K Buy
2,346
+84
+4% +$8.05K 0.06% 70
2020
Q1 		$204K Buy
2,262
+22
+1% +$2.34K 0.06% 69
2019
Q4 		$254K Buy
2,240
+383
+21% +$42K 0.07% 68
2019
Q3 		$202K Buy
+1,857
New +$194K 0.06% 71

Other funds holding MDT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Eubel Brady & Suttman Asset Management's MDT Position: Q2 2026 in Review

Eubel Brady & Suttman Asset Management increased its Medtronic (MDT) stake by 1.6% in Q2 2026, buying an estimated $414K and bringing the position to 335,820 shares worth $26.3M. The position accounts for 3.12% of the portfolio, ranked #10.

Eubel Brady & Suttman Asset Management first reported a position in MDT in Q3 2019 and has held it in 28 quarters since. The position peaked at $32M in Q3 2025. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Eubel Brady & Suttman Asset Management held 335,820 shares of Medtronic worth $26.3M as of Q2 2026.
  • Eubel Brady & Suttman Asset Management bought 5,126 Medtronic shares in Q2 2026, an estimated $414K.
  • Medtronic made up 3.12% of Eubel Brady & Suttman Asset Management's portfolio in Q2 2026, its #10 holding.
  • Eubel Brady & Suttman Asset Management first reported a position in Medtronic in Q3 2019 and has held it in 28 quarters since.
  • Eubel Brady & Suttman Asset Management's Medtronic position peaked at $32M in Q3 2025.
  • 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Eubel Brady & Suttman Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.